{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:37:09Z","timestamp":1768829829006,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015691","name":"NIAID DMID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.antiviral.2022.105295","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:03:07Z","timestamp":1648069387000},"page":"105295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-7320","authenticated-orcid":false,"given":"Justin G.","family":"Julander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Haese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Andoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel N.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-0181","authenticated-orcid":false,"given":"Pierre","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Marniquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-3158","authenticated-orcid":false,"given":"Hugh","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Mandron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105295_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2017.09.016","article-title":"Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection","volume":"149","author":"Abdelnabi","year":"2018","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.antiviral.2022.105295_bib2","doi-asserted-by":"crossref","first-page":"e0008355","DOI":"10.1371\/journal.pntd.0008355","article-title":"Chikungunya in Indonesia: epidemiology and diagnostic challenges","volume":"14","author":"Arif","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2022.105295_bib3","doi-asserted-by":"crossref","first-page":"e0130150","DOI":"10.1371\/journal.pone.0130150","article-title":"Development of a Hamster model for chikungunya virus infection and pathogenesis","volume":"10","author":"Bosco-Lauth","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.antiviral.2022.105295_bib4","doi-asserted-by":"crossref","first-page":"e0005637","DOI":"10.1371\/journal.pntd.0005637","article-title":"Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques","volume":"11","author":"Broeckel","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2022.105295_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4269\/ajtmh.2010.10-0290","article-title":"Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model","volume":"83","author":"Chen","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.antiviral.2022.105295_bib6","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105295_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-1-62703-484-5_33","article-title":"A mouse model of chikungunya virus with utility in antiviral studies","volume":"1030","author":"Dagley","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2022.105295_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2014.05.004","article-title":"Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)","author":"Dagley","year":"2014","journal-title":"Antiviral Res."},{"issue":"10","key":"10.1016\/j.antiviral.2022.105295_bib9","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"16","key":"10.1016\/j.antiviral.2022.105295_bib10","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1128\/JVI.02603-09","article-title":"Chikungunya virus arthritis in adult wild-type mice","volume":"84","author":"Gardner","year":"2010","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2022.105295_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2018.07.018","article-title":"Neutralizing antibodies inhibit chikungunya virus budding at the plasma membrane","volume":"24","author":"Jin","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105295_bib12","doi-asserted-by":"crossref","first-page":"104904","DOI":"10.1016\/j.antiviral.2020.104904","article-title":"Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus","volume":"182","author":"Julander","year":"2020","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.antiviral.2022.105295_bib13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105295_bib14","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41598-018-20305-4","article-title":"Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity","volume":"8","author":"Lum","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105295_bib15","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2022.105295_bib16","article-title":"Chronic chikungunya virus disease","author":"McCarthy","year":"2019","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105295_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.antiviral.2022.105295_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jir470","article-title":"Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis","volume":"204","author":"Rulli","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105295_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41541-017-0019-3","article-title":"Antibody therapies for the prevention and treatment of viral infections","volume":"2","author":"Salazar","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.antiviral.2022.105295_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.actatropica.2018.09.003","article-title":"A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control","volume":"188","author":"Silva","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.antiviral.2022.105295_bib21","doi-asserted-by":"crossref","first-page":"104651","DOI":"10.1016\/j.jcv.2020.104651","article-title":"Clinical features and laboratory diagnosis of emerging arthropod-transmitted viruses: a report from the Pan American Society for clinical virology clinical practice committee","volume":"132","author":"Starolis","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2022.105295_bib22","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/cid\/ciw589","article-title":"Viremia and clinical presentation in Nicaraguan patients infected with Zika virus, Chikungunya virus, and Dengue virus","volume":"63","author":"Waggoner","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"13","key":"10.1016\/j.antiviral.2022.105295_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"Weaver","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2022.105295_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2008.79.133","article-title":"An animal model for studying the pathogenesis of chikungunya virus infection","volume":"79","author":"Ziegler","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422200064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422200064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:17Z","timestamp":1759062917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635422200064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":24,"alternative-id":["S016635422200064X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105295","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105295"}}